BUZZ — GenScript Biotech extends gain to hit near 5 — year peak on Eli Lilly deal
* Shares of GenScript Biotech Corp jump 8.2% to HK$40.28, their highest level since December 2021 * Stock extends a rally from the previous session after announcement of collaboration with Eli Lilly and Company * Stock third-biggest pct gainer in the Hang Seng Biotech Index, which climbs 1.8% * GenScript shares closed